1. What is the Biliary Stent Market size in 2026?

The biliary stent market size is estimated at USD 739.8 million in 2026.

2. What is the Biliary Stent Market size forecast for 2035?

The biliary stent market is forecast to reach USD 1,176 million by 2035.

3. What is the CAGR of the Biliary Stent Market from 2026 to 2035?

The biliary stent market is projected to grow at a CAGR of 5.26% from 2026 to 2035.

5. Which product type segment is growing fastest in the Market?

Biodegradable biliary stents are the fastest-growing product type segment, expanding at a 16.32% CAGR from 2026 to 2035.

6. Which region leads the Biliary Stent Market?

North America leads the biliary stent market, accounting for approximately 38% revenue share in 2025.

7. Which region is the fastest-growing in the Biliary Stent Market?

Asia-Pacific is the fastest-growing region, expanding at a 7.75% CAGR from 2026 to 2035.

8. Which country holds the largest Biliary Stent Market share?

The U.S. holds the largest country-level share, with a market size of approximately USD 210.19 million in 2025.

9. Who are the key players in the Biliary Stent Market?

Key players include Boston Scientific Corporation, Cook Medical LLC, Olympus Corporation, Medtronic plc, and Becton, Dickinson and Company, among 20 companies profiled in this report.

10. What are the key growth drivers of the Biliary Stent Market?

Rising incidence of pancreatic and biliary tract malignancies and growing covered metal stent adoption are key drivers, with the Ambulatory Surgical Centers end-user segment growing at an 11.70% CAGR.

11. What factors restrain Biliary Stent Market growth?

Risk of stent occlusion and migration restrains long-term outcomes, affecting adoption even within the dominant Biliary Obstruction application segment holding approximately 68% of 2025 revenue.

12. What opportunities exist in the Biliary Stent Market?

Biodegradable stent commercialization and ambulatory surgical center -focused product design present strong opportunities, with Distributor Sales growing at a 7.09% CAGR from 2026 to 2035.

13. How is technology influencing the Biliary Stent Market?

Biodegradable polymer and bioresorbable metal stent technology is reshaping the market, with Biodegradable Biliary Stents growing at a 16.32% CAGR. This trajectory suggests removal-free stent designs will become a standard option for benign stricture management by the end of the forecast period.

14. What regulations shape the Biliary Stent Market?

Regulations including U.S. FDA 510(k) clearance and the FDA's finalized metal expandable biliary stent guidance shape deployment across the roughly 58% share held by Metal Biliary Stents. Continued regulatory clarity is likely to accelerate biodegradable stent adoption over the forecast period.

Biliary Stent Market

Name: Biliary Stent Market
Creator: Next Move Strategy Consulting
Published: 2026-09-19T00:00:00+00:00
License: https://www.nextmsc.com/privacy-policy

Research Methodology

At Next Move Strategy Consulting, we understand that insightful market research is the cornerstone of successful business decisions. That's why we employ a robust and multifaceted approach, combining various methodologies to deliver the most accurate and actionable data for our clients.

Research Methodology Nmsc Updated

Research Landscape

We navigate the world of research with two primary approaches:

Qualitative Approach

Our qualitative research methodologies involve immersive techniques such as in-depth interviews, focus groups, and observational studies. By engaging directly with individuals and stakeholders, we uncover valuable insights that quantitative data alone may overlook.

Quantitative Research

In tandem with qualitative methodologies, NMSC leverages the power of Quantitative Research to provide a robust foundation of numerical insights. Through systematic data collection and analysis, we quantify patterns, preferences, and market trends, offering a comprehensive view of the business landscape.

Our quantitative research approach employs diverse tools, including surveys, experiments, and statistical modelling. These methodologies enable us to gather data from a large and representative sample, ensuring the statistical significance of our findings. By employing structured questionnaires and standardized data collection methods, we guarantee the reliability and validity of the information we present to our clients.

Quantitative research is particularly effective in measuring the prevalence of trends, assessing market size, and gauging the impact of various factors on consumer behavior. The numerical precision attained through this approach equips our clients with actionable insights, facilitating data-driven decision-making and strategy formulation.

Our Specialized Toolbox for Industry-Specific Market Research

We deploy a specialized arsenal of techniques tailored to meet your unique requirements. Here's a glimpse into our comprehensive toolbox:

Information Procurement

The stage entails acquiring market data or relevant information through various sources and methodologies.

Market Research Approach

We utilize both top-down and bottom-up approaches in market research analysis to achieve a comprehensive understanding of the market dynamics, leveraging the broad perspective of industry trends and macroeconomic factors alongside detailed insights from specific segments and individual companies.

Porters Five Forces Analysis

We conduct Porter's Five Forces analysis to evaluate the competitive landscape of an industry, providing us with insights into factors that affect profitability and strategic positioning.

Porters 5 Updated 2

SWOT Analysis

Forecasting

We utilize a forecasting model to predict future consumption by considering parameters like population, economics, regulations, market competition, drivers, constraints, technology, and pricing. We also employ statistical techniques such as multilinear regression, exponential smoothing, moving average, ARIMA, and Monte Carlo simulations for accurate predictions. In econometric forecasting, we analyzed short-term and long-term event impacts, attributing values based on regulatory frameworks, economic factors, and market events.

What Is the Biliary Stent Market Size?

The global biliary stent market size was valued at USD 691.4 million in 2025 and is estimated at USD 739.8 million in 2026, projected to reach USD 1,176 million by 2035, growing at a CAGR of 5.26% from 2026 to 2035. North America led the market with an approximate 38% revenue share in 2025, while the Metal Biliary Stents product segment dominated at roughly 58% share.

Our findings suggest that the following key takeaways summarize the biliary stent market's segment-level and geographic dynamics as of 2025.

Biliary Stent Market Global Industry Analysis and Forecast (2026-2035) Revenue Forecast

Values in USD Million

2025 $691.4 Million

2025

2026 $727.8 Million

2026

2027 $766.0 Million

2027

2028 $806.3 Million

2028

2029 $848.8 Million

2029

2030 $893.4 Million

2030

2031 $940.4 Million

2031

2032 $989.9 Million

2032

2033 $1,041.9 Million

2033

2034 $1,096.7 Million

2034

2035 $1,176.0 Million

2035

Key Takeaways

By Product Type: Metal Biliary Stents held the largest share, expanding from USD 401.01 million in 2025 to USD 635.04 million by 2035; Biodegradable Biliary Stents are the fastest-growing sub-segment at 16.32% CAGR from 2026–2035.

By Application: Biliary Obstruction held the largest share, accounting for approximately 68% of the market and USD 470.15 million in 2025; Biliary Leak is the fastest-growing sub-segment at 7.47% CAGR from 2026–2035.

By End-User: Hospitals held the largest share, accounting for approximately 72% and USD 497.81 million in 2025; Ambulatory Surgical Centers are the fastest-growing sub-segment at 11.70% CAGR from 2026–2035.

By Sales Channel: Direct Sales held the largest share, accounting for approximately 54% and USD 373.36 million in 2025; Distributor Sales are the fastest-growing sub-segment at 7.09% CAGR from 2026–2035.

Dominant Region: North America dominated with approximately 38% revenue share in 2025, valued at USD 262.73 million.

Fastest-Growing Region: Asia-Pacific is expected to register the highest CAGR of 7.75% during 2026–2035.

Dominant Country: The U.S. led the market, accounting for USD 210.19 million in revenue in 2025.

Fastest-Growing Country: India is the fastest-growing country, registering a CAGR of 10.33% during 2026–2035.

Market Opportunity: The biliary stent market presents an absolute dollar opportunity of approximately USD 436.2 million between 2026 and 2035, calculated as the difference between the 2035 forecast value and the 2026 base value, an investment window favoring manufacturers scaling biodegradable and fully covered self-expanding metal stent platforms.

According to NMSC analysis, we found that the gap between rising benign biliary stricture recurrence rates and the still-limited adoption of biodegradable stent technology is widening the addressable market for polymer and bioresorbable metal platforms, even as established metal stent designs remain the clinical standard for malignant obstruction.

Ecosystem Analysis of the Biliary Stent Industry

The above infographic provides a detailed ecosystem analysis of the biliary stent market, outlining key stakeholders from manufacturers and healthcare providers to regulatory bodies and patients. It illustrates the interconnected interactions across the value chain that drive the delivery of safe and effective biliary drainage solutions. The analysis further highlights the value created, such as improved clinical efficiency and enhanced patient outcomes, while identifying key trends like biocompatible materials and smart delivery systems. Ultimately, it concludes that collaboration across the ecosystem is crucial for fostering innovation and improving patient care .

Ecosystem Analysis of the Biliary Stent Market Global Industry Analysis and Forecast (2026-2035)

What does the Biliary Stent Market Encompass?

The biliary stent market encompasses plastic, metal, and biodegradable endoscopically or percutaneously placed devices used to restore bile flow in patients with malignant and benign biliary obstruction, biliary leaks, and other biliary drainage indications, spanning hospitals, ambulatory surgical centers , and specialty clinics. We observed that the market has structurally evolved from straight and pigtail plastic stents toward self-expanding metal stents with covered and partially covered designs, and more recently toward biodegradable polymer and bioresorbable metal platforms, following Olympus Corporation's 2024 integration of Taewoong Medical's metallic stent designs after its 2024 acquisition.

Regulatory pathways such as U.S. FDA 510(k) clearance and the FDA's finalized guidance on metal expandable biliary stents continue to shape product development and market entry timelines, while CE Mark requirements govern access across European markets. During our market evaluation, we noticed that endoscopy device adoption trends favor covered self-expanding metal stents for malignant obstruction, while biodegradable stent technology is advancing fastest for benign strictures requiring temporary, removal-free placement.

Key Emerging Trends

Our analysis shows that four structural trends are reshaping product design, clinical adoption, and manufacturer strategy across the global biliary stent market heading into 2035.

How Is Biodegradable Stent Technology Transforming Benign Stricture Management?

Biodegradable stent technology is transforming benign biliary stricture management by eliminating the need for a second endoscopic procedure to remove the device. The ARCHIMEDES biodegradable biliary and pancreatic stent, sponsored by QualiMed Innovative Medizinprodukte GmbH, is undergoing continued clinical evaluation for safety and performance under an active study protocol updated in 2026. Stakeholder impact is greatest for patients and endoscopists managing benign strictures, where avoiding repeat procedures reduces both clinical risk and healthcare system cost.

Why Is Post-Acquisition Portfolio Integration Reshaping Metal Stent Competition?

Post-acquisition portfolio integration is reshaping competitive dynamics in the metal stent segment, as larger endoscopy companies combine acquired specialist stent technology with established global distribution networks. Olympus Corporation completed its acquisition of Taewoong Medical in February 2024 and integrated Taewoong's metallic stent designs into its own product offerings by January 2024, expanding its biliary, esophageal , colonic, and duodenal stenting capabilities. We found that this integration model is becoming a common strategy for endoscopy companies seeking to strengthen specialized device portfolios.

How Is Multi- Center Clinical Evaluation Shaping Next-Generation Stent Design?

Multi- center clinical evaluation involving academic medical centers is shaping next-generation biliary stent design, as manufacturers seek robust clinical evidence before broader commercialization. Olympus Corporation of the Americas is sponsoring a clinical study of its HANAROSTENT Multi-Hole biliary stent in collaboration with Mayo Clinic and M. I.Tech Co., Ltd., evaluating clinical safety and performance for malignant biliary obstruction with an estimated primary completion date in 2027. Our assessment indicates that this collaborative academic-industry model is becoming standard practice for validating novel stent geometries.

Why Is Manufacturing Capacity Expansion Accelerating in Asia-Pacific?

Manufacturing capacity expansion is accelerating across Asia-Pacific as stent manufacturers position closer to both regional demand growth and global export markets. Micro-Tech (Nanjing) Co., Ltd. held a formal groundbreaking ceremony for its Thailand Manufacturing Center in January 2025, marking a significant step in the company's global expansion strategy. Based on research conducted by NMSC, we found that this regional manufacturing investment is helping Asia-based stent manufacturers compete more directly with established Western suppliers on cost and delivery timelines.

Market Drivers & Dynamics

Interactive Dataset


Rising incidence of pancreatic and biliary tract malignancies	driver	+1.4%	North America, Europe, Asia-Pacific	2026–2032
Growing adoption of covered self-expanding metal stents	driver	+1.1%	North America, Europe	2026–2031
Expanding endoscopic retrograde cholangiopancreatography procedure volume	driver	+0.9%	Global	2026–2032
Advancing biodegradable and bioresorbable stent technology	driver	+0.7%	North America, Europe	2027–2035
Manufacturing capacity expansion across Asia-Pacific	driver	+0.5%	Asia-Pacific	2026–2030
Risk of stent occlusion and migration limiting long-term outcomes	restraint	−0.9%	Global	2026–2030
Reimbursement variability for premium covered and biodegradable stents	restraint	−0.6%	Asia-Pacific, Latin America, Africa	2026–2030
Limited procedural awareness in emerging healthcare markets	restraint	−0.4%	Middle East & Africa, Latin America	2026–2029

Source: Next Move Strategy Consulting

Growth Drivers

What Is the Primary Growth Driver of the Biliary Stent Market?

Rising incidence of pancreatic and biliary tract malignancies is the single largest driver of the market demand, as malignant biliary obstruction remains the leading indication for stent placement. The U.S. FDA's finalized guidance on metal expandable biliary stents, which supersedes 1998 recommendations and establishes updated testing standards for palliative treatment of malignant strictures, reflects the sustained regulatory attention this clinical category receives. We observed that this malignancy-driven demand base provides consistent volume stability across both developed and emerging markets.

How Is Covered Self-Expanding Metal Stent Adoption Driving Market Growth?

Growing adoption of covered self-expanding metal stents is driving above-average growth within the metal stent category, as covered designs reduce tumor ingrowth and extend stent patency compared with uncovered alternatives. Boston Scientific's WallFlex Biliary RX Stent System, offered in fully covered, partially covered, and uncovered configurations, illustrates how manufacturers have expanded covered-stent options to address diverse clinical requirements. Our analysis shows that fully covered configurations are increasingly preferred where removability is clinically important.

Growth Inhibitors

What Is Restraining Biliary Stent Market Growth?

Risk of stent occlusion and migration restrains long-term clinical outcomes and can necessitate repeat procedures, particularly with plastic stents that require more frequent replacement than metal alternatives. Reimbursement variability for premium , covered , and biodegradable stent technology also restrains adoption across price-sensitive healthcare systems in Asia-Pacific, Latin America, and Africa. We found that these pressures weigh most heavily on smaller manufacturers lacking the clinical evidence base to justify premium pricing to payers.

Segmentation Analysis

2025 (USD Million)

2035 (USD Million)

Metal Biliary Stents 2025: $401.0 Million | 2035: $635.0 Million

Metal Biliar

Plastic Biliary Stents 2025: $248.9 Million | 2035: $352.8 Million

Plastic Bili

Biodegradable Biliary Stents 2025: $41.5 Million | 2035: $188.2 Million

Biodegradabl


Metal Biliary Stents	$401.0 Million	$635.0 Million	4.70%
Plastic Biliary Stents	$248.9 Million	$352.8 Million	3.55%
Biodegradable Biliary Stents	$41.5 Million	$188.2 Million	16.32%

Which Product Type Segment Dominates the Biliary Stent Market?

Metal Biliary Stents dominate the biliary stent industry with approximately a 58% share in 2025, valued at USD 401.01 million, reflecting their established role as the clinical standard for palliative treatment of malignant biliary obstruction. Biodegradable Biliary Stents are the fastest-growing product type at a 16.32% CAGR from 2026 to 2035, driven by ongoing clinical evaluation of polymer and bioresorbable metal platforms such as the ARCHIMEDES stent, which eliminate the need for a second removal procedure in benign stricture cases.

2025 (USD Million)

2035 (USD Million)

Biliary Obstruction 2025: $470.2 Million | 2035: $729.1 Million

Biliary Obst

Biliary Leak 2025: $165.9 Million | 2035: $341.0 Million

Biliary Leak

Other Biliary Drainage 2025: $55.3 Million | 2035: $105.8 Million

Other Biliar


Biliary Obstruction	$470.2 Million	$729.1 Million	4.49%
Biliary Leak	$165.9 Million	$341.0 Million	7.47%
Other Biliary Drainage	$55.3 Million	$105.8 Million	6.70%

Which Application Segment Is Growing Fastest?

Biliary Obstruction leads the application segmentation with approximately 68% share in 2025 at USD 470.15 million, anchored by the high procedure volume associated with both malignant and benign strictures requiring stent placement. Biliary Leak is the fastest-growing application segment at a 7.47% CAGR, reflecting rising post-surgical and post-transplant procedure volumes that create secondary demand for stents used in leak management alongside primary obstruction treatment.

2025 (USD Million)

2035 (USD Million)

Hospitals 2025: $497.8 Million | 2035: $752.6 Million

Hospitals

Specialty Clinics 2025: $110.6 Million | 2035: $199.9 Million

Specialty Cl

Ambulatory Surgical Centers 2025: $62.2 Million | 2035: $188.2 Million

Ambulatory S

Other Healthcare Facilities 2025: $20.7 Million | 2035: $35.3 Million

Other Health


Hospitals	$497.8 Million	$752.6 Million	4.22%
Specialty Clinics	$110.6 Million	$199.9 Million	6.10%
Ambulatory Surgical Centers	$62.2 Million	$188.2 Million	11.70%
Other Healthcare Facilities	$20.7 Million	$35.3 Million	5.46%

Which End-User Segment Leads the Biliary Stent Market?

Hospitals lead the end-user segmentation with approximately 72% share in 2025 at USD 497.81 million, anchored by their role as the primary setting for endoscopic retrograde cholangiopancreatography and percutaneous biliary drainage procedures. Ambulatory Surgical Centers are the fastest-growing end-user segment at an 11.70% CAGR, as lower-complexity biliary stenting procedures increasingly shift toward outpatient settings offering shorter procedure times and lower per- case costs.

2025 (USD Million)

2035 (USD Million)

Direct Sales

Distributor

Other Indire

Segment Item	2025 (USD Million)	2035 (USD Million)	CAGR
Direct Sales	$10.0 USD Million	$40.0 USD Million	14.0%
Distributor Sales	$17.1 USD Million	$51.1 USD Million	24.0%
Other Indirect Sales	$24.2 USD Million	$62.2 USD Million	22.0%

Segment-wise data not detailed in this view

Unlock complete segment-wise numbers for By Sales Channel.

Unlock Full Data

Growth Opportunities

Beyond the core drivers shaping overall demand, three whitespace opportunities stand out for manufacturers positioning portfolios toward 2035.

How Can Manufacturers Capture Value from Biodegradable Stent Commercialization?

Advancing clinical evidence for biodegradable polymer and bioresorbable metal stents creates a mechanism for manufacturers to capture premium pricing in benign stricture management by eliminating repeat removal procedures. Manufacturers with active, well-designed clinical trials such as the ARCHIMEDES stent program stand to benefit most from this fastest-growing product-type opportunity.

What Opportunity Exists in Ambulatory Surgical Center -Focused Product Design?

The shift of lower-complexity biliary stenting procedures toward ambulatory surgical centers creates a mechanism for manufacturers to capture volume from a rapidly growing site-of-care category. Manufacturers offering streamlined delivery systems suited to outpatient workflows are best positioned to capture this fastest-growing end-user opportunity as procedure volume continues shifting away from inpatient hospital settings.

How Can Suppliers Benefit from Post-Transplant Biliary Leak Management?

Rising post-transplant biliary leak procedure volume creates a mechanism for manufacturers to capture incremental demand from a growing complication-management category tied to expanding global transplant activity. Manufacturers with proven fully covered stent designs suited to leak sealing are best positioned to capture this fastest-growing application opportunity as transplant volumes continue rising globally.

Regional Outlook


North America	$262.7 Million	$399.8 Million	4.29%
Europe	$186.7 Million	$282.2 Million	4.22%
Asia-Pacific	$172.9 Million	$364.6 Million	7.75%
Middle East & Africa	$41.5 Million	$82.3 Million	7.09%
Latin America	$27.7 Million	$47.0 Million	5.45%

North America

2025 Size

$262.7 Million

CAGR

4.29%

North America's biliary stent market leads globally, anchored by high endoscopic retrograde cholangiopancreatography procedure volume and established reimbursement pathways supporting both metal and plastic stent adoption. Regulatory influence flows through FDA 510(k) clearance and the agency's finalized metal expandable biliary stent guidance, while technology adoption favors covered self-expanding metal stents for malignant obstruction. We observed that strategic outlook favors manufacturers with strong hospital and ambulatory surgical center distribution relationships.

Primary Driver: High ERCP procedure volume and established reimbursement pathways

Key National Markets

U.S.

Based on our estimates, the U.S. biliary stent market was valued at approximately USD 210.19 million in 2025 and is projected to reach USD 303.88 million by 2035, growing at a 3.76% CAGR. Demand is anchored in high ERCP procedure volume and established reimbursement, with Boston Scientific, Cook Medical, and Olympus supporting a mature but steadily expanding strategic outlook shaped by continued FDA clearance activity.

Canada

The market in Canada was valued at approximately USD 34.16 million in 2025 and is forecast to reach USD 51.98 million by 2035, expanding at a 4.29% CAGR. Demand structure mirrors the U.S. with steady hospital-based procedure volume, moderate ambulatory surgical center adoption, and provincial healthcare procurement standards shaping product specification.

Europe

2025 Size

$186.7 Million

CAGR

4.22%

Europe's market benefits from CE Mark harmonization enabling consistent cross-border product access and steady covered metal stent adoption across national health systems. Technology adoption favors clinically validated designs given the region's structured health technology assessment processes. Strategic outlook favors manufacturers combining proven clinical outcomes data with strong national distributor relationships across the region's fragmented reimbursement landscape.

Primary Driver: CE Mark harmonization and steady covered metal stent adoption

Key National Markets

As per our estimate, the UK market stood at approximately USD 29.87 million in 2025 and is projected to reach USD 42.34 million by 2035, growing at a 3.55% CAGR. Demand structure favors metal stent adoption within National Health Service endoscopy units, with steady procedure-volume growth supporting continued platform adoption across both malignant and benign indications.

Germany

According to our analysis, Germany's market was valued at approximately USD 41.07 million in 2025 and is expected to reach USD 59.27 million by 2035, at a 3.74% CAGR. Demand is driven by strong hospital-based endoscopy infrastructure and growing covered metal stent adoption, with regulatory alignment to EU CE Mark requirements shaping product certification pathways.

France

Based on our estimates, France's market was valued at approximately USD 24.27 million in 2025 and is projected to reach USD 36.69 million by 2035, growing at a 4.22% CAGR. Demand structure is led by steady hospital-based procedure growth, with competitive intensity concentrated among established global manufacturers serving both public and private healthcare systems.

Asia-Pacific

2025 Size

$172.9 Million

CAGR

7.75%

Asia-Pacific is the fastest-scaling major regional market by absolute dollar growth, propelled by rising biliary and pancreatic malignancy incidence across China, India, and Japan alongside expanding regional manufacturing capacity. Technology adoption spans both established metal stent designs and growing domestic manufacturing capability, exemplified by Micro-Tech's new Thailand production facility. Strategic outlook favors manufacturers able to localize production and pricing to serve the region's diverse healthcare-spending environments.

Primary Driver: Rising malignancy incidence and expanding manufacturing capacity

Key National Markets

China

The market in China was valued at approximately USD 55.31 million in 2025 and is projected to reach USD 102.08 million by 2035, growing at a 6.32% CAGR, the largest country-level market in Asia-Pacific. Demand structure spans rising domestic manufacturing capability, supported by Micro-Tech (Nanjing) and Changzhou New District Garson Medical Stent Apparatus, alongside continued adoption of established international stent platforms across major hospital networks.

India

According to our analysis, India's biliary stent market was valued at approximately USD 25.93 million in 2025 and is projected to reach USD 69.27 million by 2035, expanding at a 10.33% CAGR, the fastest growth rate among major economies covered in this report. Demand is driven by rising biliary and pancreatic malignancy incidence and expanding private hospital endoscopy infrastructure, creating substantial new demand from a comparatively small existing base.

Japan

As per our estimate, Japan's market was valued at approximately USD 27.66 million in 2025 and is projected to reach USD 43.75 million by 2035, growing at a 4.69% CAGR. Demand structure is technology-mature, with established domestic and international manufacturers competing on proven metal and plastic stent platforms within a stable regulatory environment.

South Korea

Based on our estimates, South Korea's market was valued at approximately USD 15.56 million in 2025 and is projected to reach USD 29.16 million by 2035, at a 6.49% CAGR. Demand structure benefits from the country's strong domestic stent manufacturing base, with Taewoong Medical and M. I.Tech both headquartered in South Korea and serving both domestic and export markets.

Australia

The market in Australia was valued at approximately USD 10.37 million in 2025 and is projected to reach USD 21.87 million by 2035, growing at a 7.75% CAGR. Demand structure is led by steady hospital-based endoscopy procedure growth across both public and private healthcare networks, supported by a regulatory environment favorable to established international stent platforms.

Middle East & Africa

2025 Size

$41.5 Million

CAGR

7.09%

The Middle East & Africa market is expanding steadily at a 7.09% CAGR, driven by growing hospital infrastructure and specialty endoscopy investment tied to Gulf healthcare modernization initiatives. Regulatory frameworks remain in earlier development relative to North America and Europe, giving manufacturers flexibility in market entry strategy. Strategic outlook favors manufacturers with strong regional distributor and hospital-group partnerships.

Primary Driver: Growing hospital infrastructure and specialty endoscopy investment

Key National Markets

UAE

According to our analysis, the UAE biliary stent market was valued at approximately USD 9.13 million in 2025 and is projected to reach USD 17.29 million by 2035, growing at a 6.60% CAGR. Demand structure is dominated by premium private hospital investment tied to Dubai and Abu Dhabi's positioning as regional medical tourism and healthcare hubs.

Saudi Arabia

Based on our estimates, Saudi Arabia's market was valued at approximately USD 9.96 million in 2025 and is projected to reach USD 18.93 million by 2035, growing at a 6.64% CAGR. Demand is driven by Vision 2030-linked healthcare infrastructure investment, with strong regulatory support for hospital modernization supporting broader gastrointestinal endoscopy adoption.

South Africa

As per our estimate, South Africa's market was valued at approximately USD 2.07 million in 2025 and is projected to reach USD 4.94 million by 2035, growing at a 9.06% CAGR. Demand structure combines growing private hospital investment with expanding specialty endoscopy infrastructure concentrated in major urban medical centers .

Latin America

2025 Size

$27.7 Million

CAGR

5.45%

Latin America's market is expanding as rising private hospital investment in gastrointestinal endoscopy in Brazil and Argentina drives demand for both metal and plastic stent platforms. Technology adoption remains concentrated in established, cost-effective stent designs relative to more premium-focused markets. Strategic outlook favors manufacturers building distributor and private-hospital-group partnerships ahead of anticipated regional procedure-volume growth.

Primary Driver: Rising private hospital investment in gastrointestinal endoscopy

Key National Markets

Brazil

The market in Brazil was valued at approximately USD 11.62 million in 2025 and is projected to reach USD 18.82 million by 2035, growing at a 4.94% CAGR, the largest market in Latin America. Demand structure is led by rising private hospital investment in gastrointestinal endoscopy, with manufacturers expanding distribution to serve growing procedure-volume demand.

Argentina

According to our analysis, Argentina's biliary stent market was valued at approximately USD 4.98 million in 2025 and is projected to reach USD 8.47 million by 2035, growing at a 5.46% CAGR. Demand structure reflects gradually expanding private hospital investment, with regional distributors serving as the primary channel for imported stent technology.

Supply Chain Analysis of the Biliary Stent Industry

The above infographic provides a detailed supply chain analysis of the biliary stent market, tracing the end-to-end flow from raw material suppliers through manufacturing and distribution to healthcare providers and patients. It outlines key drivers, risks, and enablers, such as raw material price volatility and the need for strategic supplier partnerships. The analysis further highlights the impactful outcomes of a streamlined chain, including improved operational efficiency, cost optimization, and better patient outcomes. Ultimately, it concludes that a resilient and agile supply chain is critical for delivering life-enhancing solutions and ensuring reliability in the market .

Competitive Landscape

Our assessment indicates that competitive intensity in the biliary stent market is shaped by a mix of diversified global endoscopy leaders and specialized Asian stent manufacturers competing on product breadth, clinical evidence depth, and manufacturing scale within the broader minimally invasive surgery device industry. Market Structure | Moderately concentrated among global endoscopy leaders at the covered metal stent tier, fragmented among specialized regional manufacturers at the plastic and economy metal stent tier. Innovation Focus | Biodegradable and bioresorbable stent development, covered self-expanding metal stent design refinement, and portfolio expansion through acquisition. M&A Activity | Selective portfolio-strengthening acquisitions, exemplified by Olympus's integration of Taewoong Medical, rather than large-scale horizontal consolidation. Source: www.nextmsc.com

How Do Companies Compete in the Biliary Stent Market?

Companies compete primarily on stent patency duration, delivery system usability, clinical evidence depth, and established hospital and endoscopy- center distribution relationships built over years of clinical use. Our analysis shows that Boston Scientific and Cook Medical compete heavily on broad, clinically validated product portfolios spanning plastic and metal stents, while Olympus competes on its expanded metallic stent capability following the Taewoong Medical integration.

Which Competitive Archetypes Dominate the Biliary Stent Industry ?

Two archetypes dominate the market: diversified global endoscopy leaders offering full-spectrum plastic and metal stent portfolios, and specialized Asian manufacturers competing on cost-effective metal stent production and design innovation. Boston Scientific exemplifies the diversified-leader archetype through its WallFlex and Advanix platforms spanning multiple stent categories, while Taewoong Medical, now integrated within Olympus, exemplifies the specialized-manufacturer archetype through its metallic stent design expertise.

How Are Companies Differentiating Through Innovation?

Innovation and differentiation increasingly center on biodegradable stent technology and expanded covered-stent configurations. The ARCHIMEDES biodegradable stent's ongoing clinical evaluation and Boston Scientific's multi-configuration WallFlex platform, offered in fully covered, partially covered, and uncovered designs, both illustrate how manufacturers are broadening clinical applicability to differentiate beyond single-configuration product lines.

What M&A and Expansion Activity Is Shaping the Market?

Expansion activity is concentrated in portfolio-strengthening acquisitions and manufacturing capacity investment rather than large-format consolidation. Olympus Corporation's 2023 acquisition of Taewoong Medical, completed with product integration by January 2024, and Micro-Tech's 2025 Thailand manufacturing center groundbreaking both illustrate how manufacturers are expanding capability and capacity through targeted, organic investment.

Key Market Players

Our assessment indicates that the following 20 companies are actively shaping product innovation, clinical evidence generation, and manufacturing scale within the global biliary stent industry .

Boston Scientific Corporation Cook Medical LLC Olympus Corporation Medtronic plc Becton, Dickinson and Company W. L. Gore & Associates, Inc. Taewoong Medical Co., Ltd. Micro-Tech (Nanjing) Co., Ltd. M.I. Tech Co., Ltd. Merit Medical Systems, Inc. STERIS plc Cordis Corporation Medi-Globe GmbH ELLA-CS, s.r.o. S&G Biotech Inc. Allium Medical Solutions Ltd. Hobbs Medical, Inc. AMG International GmbH Changzhou New District Garson Medical Stent Apparatus Co., Ltd. Leo Medical Co., Ltd.

Latest Developments

We found that recent product and manufacturing developments within the biliary stent market are concentrated on capacity expansion and clinical evidence generation across 2025 and 2026.

Date	Event
October 2025	Olympus entered an international distribution agreement making it the exclusive international distributor of the GORE VIABIL Biliary Endoprosthesis for endoscopic placement.

Expert Insights

Stuart Sherman

Clinical Director of Gastroenterology and Hepatology | Indiana University Medical Center

"“ The Advanix Biliary Stent System features significant developments in plastic stent technology . Improvements in design provide greater procedural control and efficiency while navigating tight strictures in the bile ducts, facilitating stent placement and removal. The thin wall and increased inner diameter of the stent may provide extended patency of the duct, which could improve treatment outcomes. ”"

Analyst Interpretation

Thestatement highlights the continued importance of incremental design innovation in plastic biliary stents, particularly improvements in deliverability, procedural control, and stent patency. Next Move Strategy Consulting’s analysis indicates that manufacturers are increasingly differentiating biliary stent systems through thinner walls, larger inner diameters, improved delivery mechanisms, and enhanced navigation across complex biliary strictures. Our findings suggest that innovations improving placement efficiency and extending ductal patency will remain important competitive factors as physicians prioritize reliable drainage, procedural precision, and improved treatment outcomes across benign and malignant biliary obstruction applications .

Investment Opportunities

What Capital Inflows Are Targeting the Biliary Stent Market?

Capital inflows are increasingly directed toward biodegradable stent development and regional manufacturing capacity, with Micro-Tech's Thailand facility representing a notable investment in expanded Asia-Pacific production capability. We observed that investors favor manufacturers demonstrating active, well-structured clinical trial programs, viewing rigorous evidence generation as a proxy for stronger regulatory and reimbursement positioning.

How Is Infrastructure Investment Supporting the Market Growth?

Infrastructure investment in regional manufacturing capacity and hospital-based endoscopy suites continues to underwrite biliary stent procedure growth across both established and emerging markets. Micro-Tech's Thailand Manufacturing Center groundbreaking illustrates how manufacturers are investing in geographically diversified production to serve growing regional demand. Our findings suggest that manufacturers with expanding regional manufacturing footprints are best positioned to capture this infrastructure-anchored growth through 2035.

What ESG Considerations Are Shaping Investment Decisions?

Patient safety and reduced procedural burden are central governance considerations shaping investment decisions, as biodegradable stent technology directly reduces the need for repeat endoscopic removal procedures in benign stricture cases. We found that investors increasingly treat demonstrated clinical safety data from structured trials, such as the ARCHIMEDES and HANAROSTENT studies, as governance indicators alongside conventional financial performance metrics when evaluating biliary stent manufacturers.

Key Benefits for Stakeholders

How Does This Report Benefit Enterprise and Industry Leaders?

Enterprise and industry leaders gain access to validated segmentation, competitive benchmarking, and regional demand forecasts that support product-portfolio and technology-investment decisions across the biliary stent industry. Our analysis shows that detailed product type, application, and end-user breakdowns help manufacturers align development strategy with the fastest-growing segments, including Biodegradable Biliary Stents and Ambulatory Surgical Centers .

How Does This Report Benefit Investors and Financial Analysts?

Investors and financial analysts benefit from consistent, single-point market size and CAGR estimates that support valuation and capital-allocation decisions across the biliary stent supply chain. We observed that the report's regional and segment-level growth differentials help identify which manufacturers are best positioned to capture above-market growth in biodegradable stent technology and Asia-Pacific expansion through 2035.

How Does This Report Benefit Technology Vendors and Product Teams?

Technology vendors and product teams gain insight into emerging design requirements, including biodegradable polymer formulation, covered self-expanding metal stent configurations, and ambulatory-friendly delivery systems, that are reshaping the industry. Our findings suggest that this analysis helps R&D teams prioritize development roadmaps around the Biodegradable Biliary Stents and Biliary Leak segments , showing the strongest above-market growth trajectories.

Key Market Segments Evaluated

By Product Type

Metal Biliary Stents
Plastic Biliary Stents
Biodegradable Biliary Stents

By Application

Biliary Obstruction
Biliary Leak
Other Biliary Drainage

By End-User

Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Other Healthcare Facilities

By Sales Channel

Direct Sales
Distributor Sales
Other Indirect Sales

Conclusion & Recommendations

The long-term outlook remains positive, with global revenue projected to grow from USD 691.4 million in 2025 to USD 1,176 million by 2035 at a 5.26% CAGR. We observed that rising malignancy incidence, expanding covered metal stent adoption, and advancing biodegradable stent technology will continue underpinning demand across obstruction and leak-management applications through the forecast period.

What Strategic Positioning Should Biliary Stent Manufacturers Pursue?

Manufacturers should prioritize biodegradable and covered metal stent innovation while maintaining strong hospital and ambulatory surgical center distribution relationships to capture both established and emerging demand. Our assessment indicates that manufacturers investing early in rigorous, multi- center clinical evidence generation will be best positioned to capture premium positioning as next-generation stent categories mature.

How Attractive Is the Biliary Stent Market for New Investment?

The biliary stent industry presents an attractive investment case, supported by a USD 436.2 million absolute dollar opportunity between 2026 and 2035 and above-average growth in Biodegradable Biliary Stents and Ambulatory Surgical Centers . We found that investment attractiveness is highest for manufacturers combining proven clinical evidence generation with expanding regional manufacturing capacity, positioning them to serve both mature Western markets and fast-growing Asia-Pacific demand simultaneously.

What Market Shifts and Key Risks Should Stakeholders Monitor?

Stakeholders should monitor stent occlusion and migration risk affecting long-term clinical outcomes, reimbursement variability for premium stent technology, and limited procedural awareness in emerging markets as key risks to the market. Our analysis shows that manufacturers unable to demonstrate clear clinical and economic value risk slower adoption relative to better-differentiated competitors with stronger evidence bases.

What Are the Key Growth Pathways for the Biliary Stent Market?

Key growth pathways include scaling biodegradable and bioresorbable stent platforms, deepening covered self-expanding metal stent adoption, and expanding ambulatory surgical center -ready product designs. Next Move Strategy Consulting's analysis indicates that manufacturers pursuing these pathways while maintaining rigorous clinical evidence generation will be best positioned to capture the market's projected growth through 2035.

FAQs

About the Author

Jayanta Das

Jayanta Das is Senior Analyst at Next Move Strategy Consulting, where he has spent 4.5 years covering the firm's full industry taxonomy — spanning aerospace and defense, healthcare, BFSI, energy and power, semiconductors, and beyond — rather than one specialization. His work follows NextMSC's research model, combining data mining, analytics, and secondary research to build market sizing and forecasts behind NextMSC's 2,000-plus research reports, trusted by more than 3,000 organizations globally.

About the Reviewer

Supradip Baul

Supradip Baul is an accomplished business consultant and strategist with over a decade of rich experience in market intelligence, strategy, technology, and business transformation. His work has included rigorous qualitative and quantitative analysis across multiple industries, helping clients shape investment decisions and long-term roadmaps. Earlier in his career, he was associated with Gartner, where he contributed to industry-leading reports and market share analyses. He has worked with leading global companies and holds an MBA with a dual specialization in Marketing and Finance.

Download Free Sample

Full Name *

Business Email Id *

Country Code *

Phone Number *

Message

Yes, I have read the Privacy Policy

Testimonials

View All Testimonials

NISHANT AWATE

Business Development Global Sales

Our experience working with Next Move Strategy Consulting was positive. The team was responsive, professional, and open to incorporating our specific requirements throughout the project. The India AHU market study was comprehensive and well structured, covering market value and volume forecasts, product and application segments, and key industry trends. The inclusion of both AHU and residential MVHR market insights made the study particularly relevant for our strategic market assessment. Overall, the report provides a solid foundation for evaluating market potential, identifying priority segments, and supporting business-development decisions in India.

MELANIE SAMKO

Director of Marketing

The information provided by NMSC is incredibly valuable, thank you so much for such a excellent work. I really appreciate it. I will make sure to reference all of it, in my summary document.

KISHU KANDA

Strategy Analyst

We purchased the AI Consumer Market Report from this company. Not only did they customize the report to meet our specific requirements, but they also showed great flexibility in accommodating our budget. The report we received fully met our expectations. Additionally, they provided prompt and thorough responses to both our pre-purchase and follow-up questions. We look forward to working with this company again in the future.

HENRI KNYPHAUSEN

Partner at Singulier [Ex-BCG]

I recently engaged NEXTMSC.com for a commercial due diligence project within the intralogistics sector, and I am pleased to provide a reference based on my experience. In utilizing NEXTMSC.com's services, I found their report to offer valuable insights into market dynamics and key industry players. The initial report provided a solid foundation for our analysis. However, as we were investigating a smaller target in the market, and I had specific customization requests requiring additional research. These requests included detailed information on product portfolios of various players and sub-market sizes, both inclusive and exclusive of certain product categories. NEXTMSC.com demonstrated commendable responsiveness and agility in accommodating these customization requests. Within a timeframe of 1-2 weeks, they delivered a revised report that met our specific needs. Furthermore, they were receptive to my follow-up inquiries, ensuring clarity and understanding of the data provided. The final deliverable significantly contributed to our due diligence efforts. One of NEXTMSC.com's notable strengths lies in their qualitative research capabilities. However, for future engagements, I would recommend the inclusion of a quantified market model in Excel format. Such a model would offer the ability to conduct in-depth analyses and explore various market segments, including country-specific data and subcomponent breakdowns. Based on my positive experience, I would not hesitate to work with NEXTMSC.com again. Their responsiveness, willingness to accommodate customization requests, and commitment to delivering actionable insights make them a reliable partner for commercial research projects.

DIANA TREJO

Assistant Manager

Sumitomo Corporation de Mexico, S.A. de C.V.

Recently, we purchased a report on the Mexico Data Center Market from Next Move Strategy Consulting. The service has been excellent, with support that is always timely and thoroughly professional. The information provided is interesting, highly useful, and delivered with clarity. I would highly recommend NextMSC for anyone seeking insightful and dependable analysis.

Biliary Stent Market Global Industry Analysis and Forecast (2026-2035)

Select License

Research Methodology

Qualitative Approach

Our Specialized Toolbox for Industry-Specific Market Research

Information Procurement

Market Research Approach

Porters Five Forces Analysis

SWOT Analysis

Forecasting

What Is the Biliary Stent Market Size?

Biliary Stent Market Global Industry Analysis and Forecast (2026-2035) Revenue Forecast

Key Takeaways

Ecosystem Analysis of the Biliary Stent Industry

What does the Biliary Stent Market Encompass?

Key Emerging Trends

How Is Biodegradable Stent Technology Transforming Benign Stricture Management?

Why Is Post-Acquisition Portfolio Integration Reshaping Metal Stent Competition?

How Is Multi- Center Clinical Evaluation Shaping Next-Generation Stent Design?

Why Is Manufacturing Capacity Expansion Accelerating in Asia-Pacific?

Market Drivers & Dynamics

Growth Drivers

What Is the Primary Growth Driver of the Biliary Stent Market?

How Is Covered Self-Expanding Metal Stent Adoption Driving Market Growth?

Growth Inhibitors

What Is Restraining Biliary Stent Market Growth?

Segmentation Analysis

Which Product Type Segment Dominates the Biliary Stent Market?

Which Application Segment Is Growing Fastest?

Which End-User Segment Leads the Biliary Stent Market?

Growth Opportunities

How Can Manufacturers Capture Value from Biodegradable Stent Commercialization?

What Opportunity Exists in Ambulatory Surgical Center -Focused Product Design?

How Can Suppliers Benefit from Post-Transplant Biliary Leak Management?

Regional Outlook

North America

Key National Markets

Europe

Key National Markets

Asia-Pacific

Key National Markets

Middle East & Africa

Key National Markets

Latin America

Key National Markets

Supply Chain Analysis of the Biliary Stent Industry

Competitive Landscape

How Do Companies Compete in the Biliary Stent Market?

Which Competitive Archetypes Dominate the Biliary Stent Industry ?

How Are Companies Differentiating Through Innovation?

What M&A and Expansion Activity Is Shaping the Market?

Key Market Players

Latest Developments

Expert Insights

Stuart Sherman

Analyst Interpretation

Investment Opportunities

What Capital Inflows Are Targeting the Biliary Stent Market?

How Is Infrastructure Investment Supporting the Market Growth?

What ESG Considerations Are Shaping Investment Decisions?

Key Benefits for Stakeholders

How Does This Report Benefit Enterprise and Industry Leaders?

How Does This Report Benefit Investors and Financial Analysts?

How Does This Report Benefit Technology Vendors and Product Teams?

Key Market Segments Evaluated

By Product Type

By Application

By End-User

By Sales Channel

Conclusion & Recommendations

What Strategic Positioning Should Biliary Stent Manufacturers Pursue?

How Attractive Is the Biliary Stent Market for New Investment?

What Market Shifts and Key Risks Should Stakeholders Monitor?

What Are the Key Growth Pathways for the Biliary Stent Market?

FAQs

About the Author

About the Reviewer

Download Free Sample

Testimonials

NISHANT AWATE